secwatch.observer — SEC 8-K summary
======================================

Issuer:     C4 Therapeutics, Inc. (CCCC)
CIK:        0001662579
Form:       8-K
Filed at:   2025-04-14T23:59:59+00:00
Accession:  0001628280-25-017612
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Bruce Downey to retire from Board, will not seek reelection at 2025 annual meeting
--------------------------------------------------------------------------------

- Bruce Downey notified board of retirement effective after 2025 Annual Meeting of Stockholders.
- Decision not due to any disagreement with company's strategy, operations, policies, or practices.
- Will cease as chair and member of Organization, Leadership and Compensation Committee, Audit Committee, and Nominating and Corporate Governance Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662579/000162828025017612/0001628280-25-017612-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662579/000162828025017612/cccc-20250414.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-017612

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer